ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 645835 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 645835; 2) Community: the network communities that were significantly associated with the response to NSC 645835; 3) Molecule: the relationships between components within communities and NSC 645835; 4) MDR: the compounds that were significantly associated with the NSC 645835.

NSC Compound Enrichment Correlation
NSC 13151 Null 0.0403978426119736 0.10836646
NSC 132313 Dianhydrogalactitol 0.0403978426119736 0.19341424
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0403978426119736 0.51084397
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0403978426119736 0.42081682
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0403978426119736 0.104573
NSC 269760 B8 0.0403978426119736 -0.0034476861
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0403978426119736 0.31376811
NSC 339137 PHYSALOLACTONE 0.0403978426119736 0.057576652
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0403978426119736 0.47030895
NSC 42972 Null 0.0403978426119736 0.14227205
Total:77  Current:66    [First] [Prev] [Next] [Last]